Medizinische Hochschule Hannover

Medizinische Hochschule Hannover is a university in Hannover, Germany that has taken part in 161 EU-funded projects since 2008, receiving €75.8M in EU funding and leading 39 as coordinator.

EU funding received€75.8M
EU projects161
As coordinator39
Running now33
First EU project2008
Latest project2026
CountryGermany
EU registration (PIC)999878426
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Medizinische Hochschule Hannover's own share of each project, not the project's full budget.

  • Horizon Europe€25.8M · 30 projects
  • FP7 (2007 to 2013)€25.6M · 73 projects
  • Horizon 2020€22.5M · 44 projects
  • EU4Health Programme (EU4H)€1.3M · 6 projects
  • 3rd Health Programme€486k · 4 projects
  • Justice Programme€39k · 1 project
  • Connecting Europe Facility€19k · 1 project
  • European Defence Fund (EDF)€0 · 1 project

Projects

161 EU-funded projects, newest first. Medizinische Hochschule Hannover led 39 of them as coordinator. Each links to the official record.

  • IDOH NextPartner

    Master in Infectious Diseases and One Health-IDOHNext

    Erasmus+ (ERASMUS+) · 2026–2033 · Project on the EU portal ↗

  • SOLACE PlusPartner

    Strengthening the Screening of Lung Cancer in Europe – Pilots, Learning, Uptake and Sustainability

    EU4Health Programme (EU4H) · 2026–2029 · Project on the EU portal ↗

    €96ktheir share
  • MPN2AMLCoordinator

    Identification of novel genetic regulators governing leukaemic transformation from myeloid proliferative neoplasms

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €313ktheir share
  • iNDUCARECoordinator

    OPTIMISING THE MANUFACTURING PLATFORM FOR INDIVIDUALIZED IPS CELL BASED HEART REPAIR

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €2.0Mtheir share
  • PREPAIR-VACAssociated partner

    PREParedness using Artificial Intelligence for Rapid VACcine design

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • HEARTCORECoordinator

    HUMAN-BASED ADVANCED CARDIAC SAFETY PLATFORM INTEGRATING MULTILAYER CARDIAC ORGANOIDS, MESH MEA, AND AI-BASED PROARRHYTHMIA RISK ASSESSMENT

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €695ktheir share
  • REPhRAMEPartner

    REcurrent urinary tract infection: Efficacy and safety of PHage theRapy and Microbiota transfEr

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €450ktheir share
  • SyncWormPartner

    Simultaneous Yield of Non-invasive uterine Contractions via Wearable Observation and Real-time Monitoring A wearable platform for dynamic uterine motion capture.

    Horizon Europe · 2026–2027 · Project on CORDIS ↗

    €30ktheir share
  • BESPOKECoordinator

    BESPOKE – Bacterial Enzyme and Surface Polymer Exploration Kit

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €2.0Mtheir share
  • EuroVisionCoordinator

    Saving vision: expanding use of lentiviral gene therapy to fight blindness

    Horizon Europe · 2026–2027 · Project on CORDIS ↗

    €150ktheir share
  • MIGRATeCoordinator

    Molecular Imaging to Guide Repair and Advance Therapy: Targeting the inflammation-fibrosis axis in ischemic heart disease and remote organs

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €1.9Mtheir share
  • EARTHWORMPartner

    EARTHWORM: pEristAlsis in Real-Time Human mri to study the interWOven fRequency & Microstructural properties

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €333ktheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €201ktheir share
  • KSHV-RBPomeCoordinator

    Elucidating the role of RNA-binding proteins in Kaposi’s sarcoma-associated herpesvirus infected cells during latency-reactivation switches

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €190ktheir share
  • ProtAct-UsPartner

    ProtAct-Us from long-term consequences of road crashes

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €434ktheir share
  • RESOLVEPartner

    Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €1.5Mtheir share
  • iMAClungCoordinator

    Moving cell-based immunotherapies to fight bacterial lung infections into the clinics

    Horizon Europe · 2024–2025 · Project on CORDIS ↗

    €150ktheir share
  • JAPreventNCDAssociated partner

    Cancer and other NCDs prevention –action on health determinants

    EU4Health Programme (EU4H) · 2024–2027 · Project on the EU portal ↗

  • RESILIENCEPartner

    European Strategic alliance for research, development and innovation on medical countermeasures against CBRN threats

    European Defence Fund (EDF) · 2024–2027 · Project on the EU portal ↗

  • TransplantChild23-27Partner

    ERN TransplantChild 2023-2027

    EU4Health Programme (EU4H) · 2023–2027 · Project on the EU portal ↗

    €368ktheir share
  • MAGICPartner

    Next-generation models and genetic therapies for rare neuromuscular diseases

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €1.2Mtheir share
  • Recon4IMDPartner

    Reconstruction and Computational Modelling for Inherited Metabolic Diseases

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €10ktheir share
  • PIECESPartner

    TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €687ktheir share
  • IntReALL 2020Partner

    International Study for Treatment of Childhood Relapsed ALL 2020

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €94ktheir share
  • HyperTargIPS-NKPartner

    Hyper-targeting CAR NK cells from induced pluripotent stem cells for novel off-the-shelf anti-tumor therapies

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €990ktheir share
  • IMPACT- AMLPartner

    Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €829their share
  • SOLACEPartner

    Strengthening the screening of Lung Cancer in Europe

    EU4Health Programme (EU4H) · 2023–2026 · Project on the EU portal ↗

    €373ktheir share
  • CarrerasLeadersAssociated partner

    Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • iPYROCoordinator

    Custom-Made Designer Macrophages to Revolutionize the Safety of Parenteral Drugs

    Horizon Europe · 2023–2024 · Project on CORDIS ↗

    €150ktheir share
  • READIHEARCoordinator

    Rehabilitation and Diagnosis of Hearing Loss based on Electric Acoustic Interaction

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €2.0Mtheir share
  • CAN.HEALPartner

    Building the EU Cancer and Public Health Genomics platform

    EU4Health Programme (EU4H) · 2022–2025 · Project on the EU portal ↗

    €305ktheir share
  • REVERSECoordinator

    Circular RNAs to reverse pathological remodelling of the injured heart

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €2.5Mtheir share
  • D-SOLVECoordinator

    Understanding the individual host response against Hepatitis D Virus to develop a personalized approach for the management of hepatitis D

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €2.1Mtheir share
  • AAVolutionPartner

    Next-generation AAV vectors for liver-directed gene therapy

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €512ktheir share
  • HEALCoordinator

    HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €1.4Mtheir share
  • MY-O-SENSESCoordinator

    Pre-clinical development of a lentiviral gene therapy to treat hearing and balance loss in Usher 1B patients

    Horizon Europe · 2022–2024 · Project on CORDIS ↗

    €150ktheir share
  • FIBREXCoordinator

    Targeting cardiac fibrosis with next generation RNA therapeutics

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €2.5Mtheir share
  • DecipherHSVCoordinator

    Deciphering cellular and viral determinants of lytic HSV-1 infection, latency and reactivation

    Horizon Europe · 2022–2028 · Project on CORDIS ↗

    €1.4Mtheir share
  • RETENTIONPartner

    heaRt failurE paTient managEment and iNTerventIOns usiNg continuous patient monitoring outside hospitals and real world data

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €527ktheir share
  • ARDATPartner

    Accelerating Research & Development for Advanced Therapies

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €178ktheir share
Show 40 more projects
  • SMABEYONDPartner

    Spinal Muscular Atrophy (SMA) beyond motoneuron degeneration: multi-system aspects

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €119ktheir share
  • MEGFIBCoordinator

    Noncoding RNA MEG3 inhibitor for Heart Failure Treatment

    Horizon 2020 · 2020–2021 · Project on CORDIS ↗

    €150ktheir share
  • Comm4CHILDPartner

    Communication for Children with Hearing Impairment to optimise Language Development

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €253ktheir share
  • ALERTPartner

    Action Leveraging Evidence to Reduce perinatal morTality and morbidity in sub-Saharan Africa

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €525ktheir share
  • LiverScreenPartner

    Screening for liver fibrosis - population-based study across European countries

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €190ktheir share
  • TherVacBPartner

    THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €131ktheir share
  • iPSC2TherapyCoordinator

    From iPSC-Macrophage Biology Towards Regenerative Therapies Targeting Respiratory Infections

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €1.5Mtheir share
  • imSAVARPartner

    Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €560ktheir share
  • 2018-EU-IA-0190Partner

    eSupport ERN-LUNG

    Connecting Europe Facility · 2019–2021 · Project on the EU portal ↗

    €19ktheir share
  • 3TRPartner

    Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

    Horizon 2020 · 2019–2028 · Project on CORDIS ↗

    €286ktheir share
  • TRAIN-HEARTPartner

    TRAIN-HEART

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €253ktheir share
  • iHEARCoordinator

    Gene therapy of inherited and acquired hearing loss

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €2.0Mtheir share
  • RiViPartner

    RIGHTS OF VICTIMS OF SURVIVED BODILY HARM: IMPROVED ACCESS TO CLINICAL FORENSIC EXAMINATIONS

    Justice Programme · 2019–2021 · Project on the EU portal ↗

    €39ktheir share
  • MDOTPartner

    Medical Device Obligations Taskforce

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €801ktheir share
  • RESHAPEPartner

    Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €1.8Mtheir share
  • ESCALONPartner

    European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €145ktheir share
  • EJP RDAssociated partner

    European Joint Programme on Rare Diseases

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €29ktheir share
  • CardioReGenixPartner

    CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €1.2Mtheir share
  • MyPalPartner

    MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

    €282ktheir share
  • NanoMedTwinPartner

    Promoting smart specialization at the Technical University of Moldova by developing the field of Novel Nanomaterials for BioMedical Applications through excellence in research and twinning

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €115ktheir share
  • MgSafePartner

    Promoting patient safety by a novel combination of imaging technologies for biodegradable magnesium implants

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €253ktheir share
  • ONWAssociated partner

    Orphanet Network

    3rd Health Programme · 2018–2021 · Project on the EU portal ↗

    €169ktheir share
  • MATURE-NKCoordinator

    MAnufacturing of TUmour-REactive Natural Killer cells

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €249ktheir share
  • XHaLeCoordinator

    Hanover experimental lung research project

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €2.0Mtheir share
  • REPO-TRIALPartner

    An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €220ktheir share
  • RECOMBPartner

    Stem-cell based gene therapy for recombination deficient SCID (RECOMB)

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €559ktheir share
  • CureCNPartner

    Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €90ktheir share
  • transMedPartner

    Educating the next generation of scientists in translational medicine: Focus on eye diseases

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  • AEROFLEXPartner

    Aerodynamic and Flexible Trucks for Next Generation of Long Distance Road Transport

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €58ktheir share
  • GLIOTRAINPartner

    Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  • iAML-lncTARGETPartner

    Targeting the transcriptional landscape in infant AML

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €16ktheir share
  • ADVANTAGEPartner

    Managing Frailty. A comprehensive approach to promote a disability-free advanced age in Europe: the ADVANTAGE initiative

    3rd Health Programme · 2017–2019 · Project on the EU portal ↗

    €30ktheir share
  • INFRAFRONTIER2020Partner

    Towards enduring mouse resources and services advancing research into human health and disease

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €18ktheir share
  • HarmonicSSPartner

    HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making

    Horizon 2020 · 2017–2020 · Project on CORDIS ↗

    €278ktheir share
  • EDGEPartner

    Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €498ktheir share
  • SoftProPartner

    Synergy-based Open-source Foundations and Technologies for Prosthetics and RehabilitatiOn

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €454ktheir share
  • SCIDNETPartner

    DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID)

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €510ktheir share
  • TECHNOBEATCoordinator

    Tools and TECHNOlogies for Breakthrough in hEArt Therapies

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €1.2Mtheir share
  • miRNA-DisEASYPartner

    microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €36ktheir share
  • POSEIDONCoordinator

    novel bioreactor Platform for reprOducible, Scalable ExpansIon and cardiac DifferentiatiON of hiPSC in suspension culture

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €159ktheir share

Showing the 80 most recent of 161 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • DNA viruses
  • HIV
  • RNA
  • aeronautical engineering
  • alcohols
  • alkaline earth metals
  • allergology
  • alzheimer
  • amines
  • amyotrophic lateral sclerosis
  • antibiotic resistance
  • antibiotics
  • artificial intelligence

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime